Artículo

La versión final de este artículo es de uso interno. El editor solo permite incluir en el repositorio el artículo en su versión post-print. Por favor, si usted la posee enviela a
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

High-risk papillomaviruses are known to exert their transforming activity mainly through E7, one of their two oncoproteins. Despite its relevance, no structural information has been obtained that could explain the apparent broad binding specificity of E7. Recombinant E7 from HPV-16 purified to near homogeneity showed two species in gel filtration chromatography, one of these corresponding to a dimer with a molecular weight of 22 kDa, determined by multiangle light scattering. The E7 dimer was isolated for characterization and was shown to undergo a substantial conformational transition when changing from pH 7.0 to 5.0, with an increase in helical structure and increased solvent accessibility to hydrophobic surfaces. The protein was resistant to thermal denaturation even in the presence of SDS, and we show that persistent residual structure in the monomer is responsible for its reported anomalous electrophoretic behavior. The dimer also displays a nonglobular hydrodynamic volume based on gel filtration experiments and becomes more globular in the presence of 0.3 M guanidinium chloride, with hydrophobic surfaces becoming accessible to the solvent, as indicated by the large increase in ANS binding. At low protein concentration, dissociation of the globular E7 dimer was observed, preceding the cooperative unfolding of the structured and extended monomer. Although E7 bears properties that resemble natively unfolded polypeptides, its far-UV circular dichroism spectrum, cooperative unfolding, and exposure of ANS binding sites support a folded and extended, as opposed to disordered and fluctuating, conformation. The large increase in solvent accessibility to hydrophobic surfaces upon small pH decrease within physiological range and in mild denaturant concentrations suggests conformational properties that could have evolved to enable protein-protein recognition of the large number of cellular binding partners reported.

Registro:

Documento: Artículo
Título:High-risk (HPV16) human papillomavirus E7 oncoprotein is highly stable and extended, with conformational transitions that could explain its multiple cellular binding partners
Autor:Alonso, L.G.; García-Alai, M.M.; Nadra, A.D.; Lapeña, A.N.; Almeida, F.L.; Gualfetti, P.; De Prat-Gay, G.
Filiación:Instituto Leloir, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Patricias Argentinas 435, (1405) Buenos Aires, Argentina
Argentina, Genencor International, Inc., 925 Page Mill Road, Palo Alto, CA 94304, United States
Centro Nacional de Resonancia Magnetica Nuclear, Departamento de Bioquimica Medica, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-590, Brazil
Palabras clave:Hydrophobic surfaces; Conformations; Dimers; Hydrodynamics; Light scattering; Molecular weight; Proteins; Biochemistry; oncoprotein; article; binding affinity; circular dichroism; conformational transition; gel filtration chromatography; hydrodynamics; light scattering; molecular weight; nonhuman; priority journal; protein binding; protein conformation; protein denaturation; protein protein interaction; protein purification; protein stability; protein structure; spectral sensitivity; structure analysis; Wart virus; Anilino Naphthalenesulfonates; Cell Transformation, Viral; Circular Dichroism; Dimerization; Electrophoresis, Polyacrylamide Gel; Guanidine; Heat; Humans; Hydrogen-Ion Concentration; Hydrophobicity; Oncogene Proteins, Viral; Papillomaviridae; Protein Binding; Protein Conformation; Protein Denaturation; Protein Folding; Risk Factors; Sodium Dodecyl Sulfate; Solvents; DNA viruses; Human papillomavirus; Human papillomavirus type 16; Human papillomavirus types; Papillomavirus; Papovaviridae
Año:2002
Volumen:41
Número:33
Página de inicio:10510
Página de fin:10518
DOI: http://dx.doi.org/10.1021/bi025579n
Título revista:Biochemistry
Título revista abreviado:Biochemistry
ISSN:00062960
CODEN:BICHA
CAS:1-anilino-8-naphthalenesulfonate, 82-76-8; Anilino Naphthalenesulfonates; Guanidine, 113-00-8; Oncogene Proteins, Viral; Sodium Dodecyl Sulfate, 151-21-3; Solvents; oncogene protein E7, Human papillomavirus type 16
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00062960_v41_n33_p10510_Alonso

Referencias:

  • Zur Hausen, H., (1996) Biochim. Biophys. Acta, 1288, pp. 55-78
  • Tommasino, M., Crawford, L., (1995) Bioassays, 17, pp. 509-518
  • Cole, S.T., Danos, O., (1987) J. Mol. Biol., 93, pp. 599-608
  • Barbosa, M.S., Lowy, D.R., Schiller, J.T., (1989) J. Virol., 63, pp. 1404-1407
  • McIntyre, M.C., Frattini, M.G., Grossman, S.R., Laimins, L.A., (1993) J. Virol., 67, pp. 3142-3150
  • Phelps, W.C., Yee, C.L., Munger, K., Howley, P.M., (1988) Cell, 53, pp. 539-547
  • Chellappan, S., Kraus, V.B., Kroger, B., Munger, K., Howley, P.M., Phelps, W.C., Nevins, J.R., (1992) Proc. Natl. Acad. Sci. U. S. A., 89, pp. 4549-4553
  • Munger, K., Werness, B.A., Dyson, N., Phelps, W.C., Harlow, E., Howley, P.M., (1989) EMBO J., 8, pp. 4099-4105
  • Dyson, N., Howley, P.M., Munger, K., Harlow, E., (1989) Science, 243, pp. 934-937
  • McIntyre, M.C., Ruesch, M.N., Laimins, L.A., (1996) Virology, 215, pp. 73-82
  • Massimi, P., Banks, L., (1997) Virology, 227, pp. 255-259
  • Munger, K., Halpern, A.L., (1995) HPV Sequence Database, pp. III58-III73. , Los Alamos National Laboratory, Los Alamos, NM
  • Zwerschke, W., Mazurek, S., Massimi, P., Banks, L., Eigenbrodt, E., Jansen-Durr, P., (1999) Proc. Natl. Acad. Sci. U.S.A., 96, pp. 1291-1296
  • Mazurek, S., Zwerschke, W., Jansen-Durr, P., Eigenbrodt, E., (2001) Biochem. J., 356, pp. 247-256
  • Brehm, A., Nielsen, S.J., Miska, E.A., McCance, D.J., Reid, J.L., Bannister, A.J., Kouzarides, T., (1999) EMBO J., 18, pp. 2449-2458
  • Tommasino, M., Adamczewski, P.J., Carlotti, F., Barth, C.F., Manetti, R., Contorni, M., Cavalieri, F., Crawdford, L., (1993) Oncogene, 8, pp. 195-202
  • Pahel, G., Aulabaugh, A., Short, S.A., Barnes, J.A., Painter, G.R., Ray, P., Phelps, W.C., (1993) J. Biol. Chem., 268, pp. 26018-26025
  • Clements, A., Johnston, K., Mazzarelli, J.M., Ricciardi, R.P., Marmorstein, R., (2000) Biochemistry, 39, pp. 16033-16045
  • Hunt, J.B., Neece, S.H., Ginsburg, A., (1985) Anal. Biochem., 146, pp. 150-157
  • Laemmli, U.K., (1970) Nature, 227, pp. 680-685
  • Schagger, H., Von Jagow, G., (1987) Anal. Biochem., 166, pp. 368-379
  • Jelesarov, I., Durr, E., Thomas, R.M., Bosshard, H.R., (1998) Biochemistry, 37, pp. 7539-7550
  • Sang, B.C., Barbosa, M.S., (1992) Proc. Natl. Acad. Sci. U.S.A., 89, pp. 8063-8067
  • Armstrong, D.J., Roman, A., (1993) Biochem. Biophys. Res. Commun., 192, pp. 1380-1387
  • Kirk, W.R., Kurian, E., Prendergast, F.G., (1996) Biophys. J., 70, pp. 69-83
  • Lima, L.M., De Prat-Gay, G., (1997) J. Biol. Chem., 272, pp. 19295-19303
  • Howley, P.M., Lowy, D.R., (2001) Fields Virology, pp. 2197-2231. , (Knipe, D. M., and Howley, P. M., Eds.), Lippincott, Williams & Wilkins, Philadelphia
  • Imai, Y., Matsushima, Y., Sugimura, T., Terada, M., (1991) J. Virol., 65, pp. 4966-4972
  • Patrick, D.R., Zhang, K., Defeo-Jones, D., Vuocolo, G.R., Maigetter, R.Z., Sardana, M.K., Oliff, A., Heimbrook, D.C., (1992) J. Biol. Chem., 267, pp. 6910-6915
  • Brokaw, J.L., Yee, C.L., Munger, K., (1994) Virology, 205, pp. 603-607
  • Tourmadje, A., Johnson, C.W., (1995) J. Am. Chem. Soc., 117, pp. 7023-7024
  • Weinreb, P.H., Zhen, W., Poon, A.W., Conway, A.K., Lansbury, P.T., (1996) Biochemistry, 35, pp. 13709-13715
  • Uversky, V.N., Gillespie, J.R., Millett, I.S., Khodyakova, A.V., Vasiliev, A.M., Chemovskaya, T.V., Vasilenko, R.N., Abramov, V.M., (1999) Biochemistry, 38, pp. 15009-15016
  • Uversky, V.N., Gillespie, J.R., Fink, A.L., (2000) Proteins, 41, pp. 415-427

Citas:

---------- APA ----------
Alonso, L.G., García-Alai, M.M., Nadra, A.D., Lapeña, A.N., Almeida, F.L., Gualfetti, P. & De Prat-Gay, G. (2002) . High-risk (HPV16) human papillomavirus E7 oncoprotein is highly stable and extended, with conformational transitions that could explain its multiple cellular binding partners. Biochemistry, 41(33), 10510-10518.
http://dx.doi.org/10.1021/bi025579n
---------- CHICAGO ----------
Alonso, L.G., García-Alai, M.M., Nadra, A.D., Lapeña, A.N., Almeida, F.L., Gualfetti, P., et al. "High-risk (HPV16) human papillomavirus E7 oncoprotein is highly stable and extended, with conformational transitions that could explain its multiple cellular binding partners" . Biochemistry 41, no. 33 (2002) : 10510-10518.
http://dx.doi.org/10.1021/bi025579n
---------- MLA ----------
Alonso, L.G., García-Alai, M.M., Nadra, A.D., Lapeña, A.N., Almeida, F.L., Gualfetti, P., et al. "High-risk (HPV16) human papillomavirus E7 oncoprotein is highly stable and extended, with conformational transitions that could explain its multiple cellular binding partners" . Biochemistry, vol. 41, no. 33, 2002, pp. 10510-10518.
http://dx.doi.org/10.1021/bi025579n
---------- VANCOUVER ----------
Alonso, L.G., García-Alai, M.M., Nadra, A.D., Lapeña, A.N., Almeida, F.L., Gualfetti, P., et al. High-risk (HPV16) human papillomavirus E7 oncoprotein is highly stable and extended, with conformational transitions that could explain its multiple cellular binding partners. Biochemistry. 2002;41(33):10510-10518.
http://dx.doi.org/10.1021/bi025579n